Your browser doesn't support javascript.
loading
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo.
Baroni, Matteo Libero; Sanchez Martinez, Diego; Gutierrez Aguera, Francisco; Roca Ho, Heleia; Castella, Maria; Zanetti, Samanta Romina; Velasco Hernandez, Talia; Diaz de la Guardia, Rafael; Castaño, Julio; Anguita, Eduardo; Vives, Susana; Nomdedeu, Josep; Lapillone, Helene; Bras, Anne E; van der Velden, Vincent H J; Junca, Jordi; Marin, Pedro; Bataller, Alex; Esteve, Jordi; Vick, Binje; Jeremias, Irmela; Lopez, Angel; Sorigue, Marc; Bueno, Clara; Menendez, Pablo.
Afiliação
  • Baroni ML; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Sanchez Martinez D; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Gutierrez Aguera F; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Roca Ho H; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Castella M; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Zanetti SR; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Velasco Hernandez T; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Diaz de la Guardia R; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Castaño J; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Anguita E; Hematology and Hemotherapy Department, Hospital Clinico Universitario San Carlos Instituto Cardiovascular, Madrid, Comunidad de Madrid, Spain.
  • Vives S; Hematology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalunya, Spain.
  • Nomdedeu J; Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain.
  • Lapillone H; Centre de Recherce Saint-Antoine, Armand-Trousseau Childrens Hospital, Paris, Île-de-France, France.
  • Bras AE; Immunology Department, Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands.
  • van der Velden VHJ; Immunology Department, Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands.
  • Junca J; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
  • Marin P; Hematology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalunya, Spain.
  • Bataller A; Hematology Department, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
  • Esteve J; Hematology Department, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
  • Vick B; Hematology Department, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
  • Jeremias I; Helmholtz Center, Munich German Research Center for Environmental Health, Neuherberg, Bayern, Germany.
  • Lopez A; Helmholtz Center, Munich German Research Center for Environmental Health, Neuherberg, Bayern, Germany.
  • Sorigue M; Pediatrics Department, Munich University Hospital Dr von Hauner Children's Hospital, Munchen, Bayern, Germany.
  • Bueno C; Human Immunology Department, Centre for Cancer Biology, Adelaide, South Australia, Australia.
  • Menendez P; Biomedicine, Research Institute Against Leukemia Josep Carreras, Barcelona, Catalunya, Spain.
J Immunother Cancer ; 8(1)2020 06.
Article em En | MEDLINE | ID: mdl-32527933

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos / Linfócitos T / Imunoterapia Adotiva / Antígenos CD28 / Subunidade alfa de Receptor de Interleucina-3 / Engenharia Celular / Hematopoese Limite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos / Linfócitos T / Imunoterapia Adotiva / Antígenos CD28 / Subunidade alfa de Receptor de Interleucina-3 / Engenharia Celular / Hematopoese Limite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido